Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Kidney International. Supplement|June 1, 1996
Aging abolishes the renal response to L-arginine infusion in essential hypertensionC Campo, V Lahera, R Garcia-Robles, et al.
Journal of the American Society of Nephrology : JASN|January 16, 1999
Pressure natriuresis in nitric oxide-deficient hypertensive rats: effect of antihypertensive treatmentsL A Fortepiani, E Rodrigo, M C Ortíz, et al.
Hormone Research|January 1, 1984
A radioimmunoassay method for measurement of urinary kininsF J del Cañizo-Gomez, F Durán, V Lahera, et al.
Virchows Archiv : an International Journal of Pathology|January 9, 2001
The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbitsP Aragoncillo, R Maeso, S Vázquez-Pérez, et al.
International Journal of Obesity (2005)|February 9, 2016
Galectin-3 inhibition prevents adipose tissue remodelling in obesityE Martínez-Martínez, L Calvier, P Rossignol, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|April 1, 2011
Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-γ)M Miana, N de Las Heras, C Rodriguez, et al.
Journal of Hypertension|May 1, 2001
Relevance of endothelium-derived hyperpolarizing factor in the effects of hypertension on rat coronary relaxationsS Vázquez-Pérez, J Navarro-Cid, N de las Heras, et al.
International Journal of Obesity (2005)|March 4, 2014
The potential role of leptin in the vascular remodeling associated with obesityE Martínez-Martínez, M Miana, R Jurado-López, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 5, 2008
Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteriesG A Wiggers, F M Peçanha, A M Briones, et al.
Experimental Physiology|January 22, 2013
Relevance of vascular peroxisome proliferator-activated receptor γ coactivator-1α to molecular alterations in atherosclerosisM Valero-Muñoz, B Martín-Fernández, S Ballesteros, et al.
Pageof 6